recall
saveGlenmark Pharmaceuticals Inc., USA recall (Cls II)
community read0 votes
chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, Manufactured for: Glenmark Pharmaceuticals Inc., NJ; Product of India, NDC 68462-862-01 — Reason: CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per current FDA recommended limit. — Status: Ongoing
view source ↗Data sources
last refreshed 6m ago
Found something off?
same company · ±60 days · 6
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Jan 1, 2025
- recallLupin Pharmaceuticals Inc. recall (Cls II)Jan 8, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls II)Jan 15, 2025
- recallGranules Pharmaceuticals Inc. recall (Cls II)Jan 15, 2025
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Dec 11, 2024
- recallGlenmark Pharmaceuticals Inc., USA recall (Cls II)Dec 11, 2024
comments(0)
5-min edit window · permanent after that